{"nct_id":"NCT01908426","title":"Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2013-09-26","start_date_type":null,"primary_completion_date":"2017-10-16","primary_completion_date_type":"ACTUAL","completion_date":"2021-01-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["EXEL"]}